Biotech services
Owkin has raised €295M across 6 funding rounds from 8 investors, most recently a Grant round in Mar 2023. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-31 | Grant | €33M | French Government | View deal → |
| 2022-06-08 | Series B | €74M | Bristol Myers Squibb | View deal → |
| 2021-11-18 | Other | €159M | Sanofi | View deal → |
| 2020-06-30 | Series A | €16M | Bpifrance,Mubadala Capital | Ventures US | View deal → |
| 2018-02-01 | Other | €4.0M | Google Ventures | View deal → |
| 2018-01-01 | Series A | €9.2M | Otium Venture alongside Cathay Innovation,Plug and Play and NJF Capital. | View deal → |
